Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability.
https://doi.org/10.14341/2071-8713-5119
For citations:
Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability. Obesity and metabolism. 2009;6(1):52-54. https://doi.org/10.14341/2071-8713-5119
Views:
366
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
